← Evidence map

ArticleDermatology and therapy2025

Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials.

April W Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 40113724